[go: up one dir, main page]

AU4501699A - Aminoazole compounds - Google Patents

Aminoazole compounds

Info

Publication number
AU4501699A
AU4501699A AU45016/99A AU4501699A AU4501699A AU 4501699 A AU4501699 A AU 4501699A AU 45016/99 A AU45016/99 A AU 45016/99A AU 4501699 A AU4501699 A AU 4501699A AU 4501699 A AU4501699 A AU 4501699A
Authority
AU
Australia
Prior art keywords
aminoazole
compounds
aminoazole compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45016/99A
Inventor
Not Given Name
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU4501699A publication Critical patent/AU4501699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU45016/99A 1998-05-29 1999-05-27 Aminoazole compounds Abandoned AU4501699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998124175 DE19824175A1 (en) 1998-05-29 1998-05-29 Amino azole compounds
DE19824175 1998-05-29
PCT/EP1999/003682 WO1999062892A1 (en) 1998-05-29 1999-05-27 Aminoazole compounds

Publications (1)

Publication Number Publication Date
AU4501699A true AU4501699A (en) 1999-12-20

Family

ID=7869385

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45016/99A Abandoned AU4501699A (en) 1998-05-29 1999-05-27 Aminoazole compounds

Country Status (4)

Country Link
AU (1) AU4501699A (en)
CO (1) CO5070569A1 (en)
DE (1) DE19824175A1 (en)
WO (1) WO1999062892A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191160B1 (en) 1998-11-10 2001-02-20 Merck & Co., Inc. Spiro-indolines as Y5 receptor antagonists
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
DE60034783T2 (en) * 1999-04-22 2008-01-31 H. Lundbeck A/S, Valby SELECTIVE NPY (Y5) ANTAGONISTS
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
HUP0202682A3 (en) 1999-09-10 2003-03-28 Merck & Co Inc Tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
AU2001246494A1 (en) * 2000-03-03 2001-09-12 Novartis Ag Condensed thiazolamines and their use as neuropeptide y5 antagonists
ATE316088T1 (en) 2001-06-22 2006-02-15 Merck & Co Inc TYROSINE KINASE INHIBITORS
CA2469790A1 (en) * 2001-12-17 2003-06-26 Merck & Co., Inc. Method for treating circadian rhythm disruptions
RU2004129285A (en) 2002-02-28 2005-10-27 Ф.Хоффманн-Ля Рош Аг (Ch) THIAZOLE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS
US6872724B2 (en) 2002-07-24 2005-03-29 Merck & Co., Inc. Polymorphs with tyrosine kinase activity
CN100381429C (en) * 2002-08-07 2008-04-16 霍夫曼-拉罗奇有限公司 Thiazole derivatives
CN100422179C (en) * 2003-08-12 2008-10-01 霍夫曼-拉罗奇有限公司 2-Amino-5-benzoylthiazole NPY antagonist
CA2533464A1 (en) * 2003-08-12 2005-02-17 F. Hoffmann-La Roche Ag Thiazole derivatives as npy antagonists
AR081626A1 (en) 2010-04-23 2012-10-10 Cytokinetics Inc AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS
AR081331A1 (en) 2010-04-23 2012-08-08 Cytokinetics Inc AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4326465A1 (en) * 1993-01-20 1995-02-09 Thomae Gmbh Dr K Amino acid derivatives, pharmaceutical compositions containing these compounds and process for their preparation
DE19544687A1 (en) * 1995-11-30 1997-06-05 Thomae Gmbh Dr K Amino acid derivatives, medicaments containing these compounds and processes for their preparation
WO1997020821A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Heteroaryl derivatives
TW399051B (en) * 1996-01-31 2000-07-21 Ssp Co Ltd A novel benzoazine thiazolidinedione derivative and pharmaceutical composition for reducing blood glucose
CA2278739A1 (en) * 1997-01-28 1998-07-30 Emma R. Parmee Thiazole benzenesulfonamides as .beta.3 agonists for the treatment of diabetes and obesity
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
DE19824175A1 (en) 1999-12-02
WO1999062892A1 (en) 1999-12-09
CO5070569A1 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
AU2863899A (en) New compounds
AU4580599A (en) Stable no-delivering compounds
AU3485999A (en) Neo-tryptophan
AUPP796798A0 (en) New compound
AU4260199A (en) Novel compounds
AU1424200A (en) Compounds
AU4501699A (en) Aminoazole compounds
AU5980899A (en) Novel compounds
AU2014800A (en) Novel compounds
AU1434500A (en) Compounds
AU3437799A (en) City-car
AU3522399A (en) Carvedilol-galenics
AU4814699A (en) Novel compounds
AUPP549998A0 (en) New compound
AU5516599A (en) Substituted 3-aryl-pyrazoles
AU2187799A (en) Novel taxaneterpine compounds
AU4507899A (en) Substituted n-aryl-o-alkyl-carbamates
AU2609599A (en) Sensor-coupling
AU4511499A (en) Substituted cyclooctadepsipeptides
AU2069199A (en) Codelets
AU2863799A (en) New compounds
AU2725599A (en) Substituted alxoxycarbonyl compounds
AU3347599A (en) Aeromobile
AU5661399A (en) Compounds
AU1192300A (en) Novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase